FDA Expands Authorized Use of REGEN-COV™ (casirivimab and imdevimab)
Go back to FDA Expands Authorized Use of REGEN-COV™ (casirivimab and imdevimab)| Regeneron (NASDAQ: REGN) | Delayed: 840.84 +30.60 (3.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $810.24 | 52 Week High | $592.36 | |||
| Open | $817.17 | 52 Week Low | $325.35 | |||
| Day High | $844.92 | P/E | 220.69 | |||
| Day Low | $815.38 | EPS | $3.81 | |||
| Volume | 750,414 | |||||
